End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,613 KRW | -0.12% | -0.62% | -18.58% |
2023 | ChoA Pharmaceutical Co., LTD. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2022 | ChoA Pharmaceutical Co., LTD.(KOSDAQ:A034940) dropped from S&P Global BMI Index | CI |
Sales 2022 | 68.88B 49.8M 68.6M | Sales 2023 | 62.97B 45.53M 62.72M | Capitalization | 61.37B 44.37M 61.13M |
---|---|---|---|---|---|
Net income 2022 | 561M 406K 559K | Net income 2023 | -10.51B -7.6M -10.47M | EV / Sales 2022 | 1.21 x |
Net Debt 2022 | 10.23B 7.4M 10.19M | Net Debt 2023 | 13.14B 9.5M 13.09M | EV / Sales 2023 | 1.18 x |
P/E ratio 2022 |
130
x | P/E ratio 2023 |
-5.84
x | Employees | 258 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 80% |
1 day | -0.12% | ||
1 week | -0.62% | ||
Current month | -11.18% | ||
1 month | -11.18% | ||
3 months | -11.32% | ||
6 months | -24.27% | ||
Current year | -18.58% |
Managers | Title | Age | Since |
---|---|---|---|
Sung-Bae Cho
CEO | Chief Executive Officer | 51 | 14-10-16 |
Sung-Hwan Cho
CEO | Chief Executive Officer | 53 | 02-02-17 |
Joon-Hyeong Son
BRD | Director/Board Member | 56 | 04-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Won-Ki Cho
CHM | Chairman | 84 | 87-12-31 |
Sung-Hwan Cho
CEO | Chief Executive Officer | 53 | 02-02-17 |
Joon-Hyeong Son
BRD | Director/Board Member | 56 | 04-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 1,613 | -0.12% | 32,654 |
24-04-29 | 1,615 | +0.62% | 43,002 |
24-04-26 | 1,605 | -0.74% | 27,749 |
24-04-25 | 1,617 | -0.49% | 59,942 |
24-04-24 | 1,625 | +0.49% | 39,875 |
End-of-day quote Korea S.E., April 29, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-18.58% | 36.37M | |
+19.27% | 43.75B | |
+27.47% | 22.06B | |
+15.11% | 14.46B | |
+12.33% | 13.62B | |
+38.36% | 11.61B | |
-9.54% | 6.9B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.32B |
- Stock Market
- Equities
- A034940 Stock